Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPB vs Capsaicin vs Botox-A for Chronic Neuropathic Pain in Post-mastectomy Syndrome
NCT06807164Phase 2Withdrawn
- Sponsor
- Centre Oscar Lambret
- Start
- Jun 2025
- Primary completion
- Sep 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of botulinum toxin type A, ropivacaine, clonidine in Post-mastectomy pain syndrome (PMPS), sponsored by Centre Oscar Lambret. Planned start Jun 2025; status: withdrawn.
02
Drugs
botulinum toxin type Aropivacaineclonidine
03
Conditions
Post-mastectomy pain syndrome (PMPS)
Beyond the preview
Go deeper on NCT06807164.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06807164.